BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22334727)

  • 1. Profile of microvolt T-wave alternans testing in 1003 patients hospitalized with heart failure.
    Jackson CE; Myles RC; Tsorlalis IK; Dalzell JR; Spooner RJ; Rodgers JR; Bezlyak V; Greenlaw N; Ford I; Cobbe SM; Petrie MC; McMurray JJ
    Eur J Heart Fail; 2012 Apr; 14(4):377-86. PubMed ID: 22334727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectral microvolt T-wave alternans testing has no prognostic value in patients recently hospitalized with decompensated heart failure.
    Jackson CE; Myles RC; Tsorlalis IK; Dalzell JR; Rocchiccioli JP; Rodgers JR; Spooner RJ; Greenlaw N; Ford I; Gardner RS; Cobbe SM; Petrie MC; McMurray JJ
    Eur J Heart Fail; 2013 Nov; 15(11):1253-61. PubMed ID: 23703105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial.
    Chow T; Kereiakes DJ; Onufer J; Woelfel A; Gursoy S; Peterson BJ; Brown ML; Pu W; Benditt DG;
    J Am Coll Cardiol; 2008 Nov; 52(20):1607-15. PubMed ID: 18992649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Indeterminate" microvolt T-wave alternans tests predict high risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
    Kaufman ES; Bloomfield DM; Steinman RC; Namerow PB; Costantini O; Cohen RJ; Bigger JT
    J Am Coll Cardiol; 2006 Oct; 48(7):1399-404. PubMed ID: 17010802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
    Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA
    Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The problem of indeterminate microvolt T-wave alternans results in patients with left ventricular dysfunction referred for implantable cardioverter-defibrillator implantation in the primary prevention of sudden cardiac death.
    Daniłowicz Szymanowicz L; Szwoch M; Kempa M; Raczak G
    Kardiol Pol; 2012; 70(8):795-802. PubMed ID: 22933211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction.
    Bloomfield DM; Bigger JT; Steinman RC; Namerow PB; Parides MK; Curtis AB; Kaufman ES; Davidenko JM; Shinn TS; Fontaine JM
    J Am Coll Cardiol; 2006 Jan; 47(2):456-63. PubMed ID: 16412877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal.
    Chan PS; Bartone C; Booth T; Kereiakes D; Chow T
    Am Heart J; 2007 Apr; 153(4):523-9. PubMed ID: 17383288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvolt T-wave alternans and other noninvasive predictors of serious arrhythmic events in patients with an implanted cardioverter-defibrillator.
    Sredniawa B; Kowalczyk J; Lenarczyk R; Kowalski O; Sędkowska A; Cebula S; Musialik-Łydka A; Kalarus Z
    Kardiol Pol; 2012; 70(5):447-55. PubMed ID: 22623232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic value of microvolt level T-wave alternans in patients at high risk of sudden cardiac death].
    Yang P; Guo T; Tang YM; Zhao L; Li SM; Liu ZM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):517-22. PubMed ID: 19100065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study.
    Ikeda T; Yoshino H; Sugi K; Tanno K; Shimizu H; Watanabe J; Kasamaki Y; Yoshida A; Kato T
    J Am Coll Cardiol; 2006 Dec; 48(11):2268-74. PubMed ID: 17161258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ABCD (Alternans Before Cardioverter Defibrillator) Trial: strategies using T-wave alternans to improve efficiency of sudden cardiac death prevention.
    Costantini O; Hohnloser SH; Kirk MM; Lerman BB; Baker JH; Sethuraman B; Dettmer MM; Rosenbaum DS;
    J Am Coll Cardiol; 2009 Feb; 53(6):471-9. PubMed ID: 19195603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined prognostic value of peak O(2) uptake and microvolt level T-wave alternans in patients with idiopathic dilated cardiomyopathy.
    Baravelli M; Fantoni C; Rogiani S; Farina S; Anzà C; Caltabiano V; Forzani T; Salerno-Uriarte JA
    Int J Cardiol; 2007 Sep; 121(1):23-9. PubMed ID: 17188766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung E; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2007 Jan; 49(1):50-8. PubMed ID: 17207722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Positive microvolt T-wave alternans as a marker of ventricular arrhythmia trigering during cardioverter-defibrillator implantation].
    Wierzbowski R; Michałkiewicz D; Cholewa M; Jacewicz K; Gniłka A; Adamus J
    Pol Merkur Lekarski; 2006 Oct; 21(124):310-3. PubMed ID: 17205766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of microvolt T-wave alternans on predicting outcome in patients with ischemic cardiomyopathy with and without defibrillators.
    Chow T; Saghir S; Bartone C; Goebel M; Schneider J; Booth T; Chan PS
    Am J Cardiol; 2007 Aug; 100(4):598-604. PubMed ID: 17697813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of microvolt T-wave alternans testing in identifying patients at high or low risk of sudden cardiac death.
    Merchant FM; Ikeda T; Pedretti RF; Salerno-Uriarte JA; Chow T; Chan PS; Bartone C; Hohnloser SH; Cohen RJ; Armoundas AA
    Heart Rhythm; 2012 Aug; 9(8):1256-64.e2. PubMed ID: 22406384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-invasive risk stratification for sudden cardiac death by heart rate turbulence and microvolt T-wave alternans in patients after myocardial infarction.
    Sulimov V; Okisheva E; Tsaregorodtsev D
    Europace; 2012 Dec; 14(12):1786-92. PubMed ID: 22849973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
    Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
    J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.